Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis
Open Access
- 4 February 2017
- journal article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 45 (3) , 248-256
Abstract
Background: Fibrillary glomerulonephritis is characterized by randomly arranged fibrils, approximately 20 nm in diameter by electron microscopy. Patients present with proteinuria, hematuria and kidney insufficiency, and about half of the reported patients progress to end-stage kidney disease within 4 years. The dependence of patient characteristics and outcomes on race has not been explored. In this study, we describe a cohort of patients with fibrillary glomerulonephritis and compare their clinical characteristics and outcomes with those of patients previously described. Methods: The University of North Carolina (UNC) Nephropathology Database was used to retrospectively identify patients diagnosed with fibrillary glomerulonephritis between 1985 and 2015. Of these patients, those treated at UNC were selected. Their demographic and clinical characteristics - including signs and symptoms, comorbidities, laboratory values, treatments and outcomes - were compared with those of patients described earlier. Results: Among the 287 patients identified, 42 were treated at the UNC Kidney Center. When compared to earlier cohorts, a higher frequency of black race, hepatitis C virus (HCV) infection and use of hemodialysis were noted in both black and HCV-positive patients. Autoimmune diseases, infections and malignancies were frequently observed, present in over half of all cases. Conclusion: According to this study, fibrillary glomerulonephritis represents a secondary glomerular disease process (associated with autoimmune disease, infection or malignancy) in many cases and hence screening is essential. As the screening for comorbidities increased over time, more underlying causes were identified. We noted a high frequency of HCV among black patients, suggesting a possible causative association. Treatment of underlying disease is essential for patients for the best outcome.Keywords
This publication has 29 references indexed in Scilit:
- Laser Microdissection and Proteomic Analysis of Amyloidosis, Cryoglobulinemic GN, Fibrillary GN, and Immunotactoid GlomerulopathyClinical Journal of the American Society of Nephrology, 2013
- Fibrillary GlomerulonephritisClinical Journal of the American Society of Nephrology, 2011
- FIBRILLARY GLOMERULONEPHRITIS IN RHEUMATOID ARTHRITISNephrology, 2010
- Hepatitis C Virus Infection in African AmericansClinical Infectious Diseases, 2006
- Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic featuresKidney International, 2003
- Fibrillary glomerulonephritis associated with hepatitis C viral infectionAmerican Journal of Kidney Diseases, 1997
- Clinical and pathologic features of fibrillary glomerulonephritisKidney International, 1992
- Fibrillary Glomerulonephritis in a Patient with Metastatic Carcinoma of the LiverAmerican Journal of Nephrology, 1990
- Fibrillary glomerulonephritis: An entity with unusual immunofluorescence featuresKidney International, 1987
- Nephrotic Syndrome Associated with Amyloid-Like Glomerular DepositsNephron, 1977